EarlySense debuts contact-free fertility tracker

EarlySense's Percept system captures the body's "internal signals" to help women track their fertility window. (EarlySense)

EarlySense, known for its under-the-mattress vital sign monitoring system, is launching a similar device, but for fertility tracking.

Placed under a user’s mattress, the Percept system captures the body’s “internal signals” and provide the user with information and predictions on their ovulation, menstruation, sleep patterns, vital signs and stress levels, EarlySense said in a statement.

The device learns a user’s menstrual cycle and fertility window, the company said, and it only gets more accurate with time. It uses Bluetooth to connect to a smartphone app, where users may view a calendar of their menstrual and ovulation cycles, as well as daily tips.

Featured Webinar

How to Streamline Your Clinical Research Organization's Processes End to End

Learn how implementing one platform leads to data consistency and ultimately facilitate faster clinical trials while reducing overall trial costs, leave behind spreadsheets and home-grown tools for a predictable trial and the ability to forecast unit delivery resulting in the optics you need to ensure a successful trial, and hear experts share industry trends of what is affecting the Clinical Research Organization industry today.

RELATED: Israeli startup EarlySense nabs $25M to back contact-free continuous patient monitoring

The contact-free device is an alternative to a number of methods that women currently use to track their fertility, including measuring basal body temperature or wearing a patch, EarlySense said.

"With today's busy and hectic lifestyles, women want more readily available data to control their fertility. The need has translated into millions of downloads of period-tracking apps. However, despite this uptick in app downloads—fully convenient, medically-proven and accurate solutions had yet to be created," said CEO Avner Halperin, in the statement. "Knowing this, EarlySense is providing the world's first practically effortless and extremely accurate fertility tracker.”

EarlySense markets a number of contact-free patient monitoring devices, including systems for hospital use and home use. Its namesake EarlySense system tracks a patient’s heart rate, respiratory rate and movement via the under-the-mattress sensor. This data is continuously displayed on a bedside monitor and at nurse stations.

RELATED: Ava bags $10M for wrist-worn fertility tracker

In September last year, the company launched its InSight platform, a modified version of its system for post-acute care settings, including nursing or rehabilitation facilities. The InSight system is tweaked to help clinicians in these settings achieve their two main outcomes: reducing rehospitalizations and preventing falls.

Suggested Articles

Peter Doshi has penned an opinion piece in the BMJ pointing out that current COVID-19 vaccine tests are not set up to save lives.

You may have heard of T cells before, but Aleks Radovic-Moreno, Be Biopharma’s co-founder, is betting on B cells as the future of cell therapies.

A patient has died in the global study of AstraZeneca’s COVID-19 vaccine, Brazil’s health authority, Anvisa, announced on Wednesday.